GlucoTrack, Inc.
GCTK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $36 | $13 | $23 | $0 |
| Gross Profit | -$36 | -$13 | -$23 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $9,485 | $4,694 | $1,947 | $1,810 |
| G&A Expenses | $0 | $0 | $0 | $2,118 |
| SG&A Expenses | $5,026 | $2,397 | $2,462 | $2,120 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $110 |
| Operating Expenses | $14,511 | $7,091 | $4,409 | $4,040 |
| Operating Income | -$14,547 | -$7,104 | -$4,432 | -$4,040 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8,050 | $7 | -$3 | -$27 |
| Pre-Tax Income | -$22,597 | -$7,097 | -$4,435 | -$4,067 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22,597 | -$7,097 | -$4,435 | -$4,067 |
| % Margin | – | – | – | – |
| EPS | 60.76 | -38.3 | -28.66 | -26.32 |
| % Growth | 258.6% | -33.6% | -8.9% | – |
| EPS Diluted | 60.76 | -38.3 | -28.66 | -26.32 |
| Weighted Avg Shares Out | 372 | 185 | 154 | 154 |
| Weighted Avg Shares Out Dil | 372 | 208 | 155 | 155 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $7 | $11 | $26 |
| Interest Expense | $583 | $0 | $3 | $0 |
| Depreciation & Amortization | $36 | $13 | $23 | $42 |
| EBITDA | -$21,978 | -$7,084 | -$4,412 | -$3,939 |
| % Margin | – | – | – | – |